Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-25-000014

PRESIDENT AND CFO sold 8,000 shares at an average $83.85 ($670,823)

  • PRESIDENT AND CFO acquired 8,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

GUGGENHIME ANDREW · PRESIDENT AND CFO

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-18 Exercise or conversion : show line 1 in the form 10b5-1 +8,000 $5.35 $42,800 117,491 D
2025-02-18 Sale : show line 2 in the form 10b5-1 −6,182 $83.64 $517,056 111,309 D
2025-02-18 Sale : show line 3 in the form 10b5-1 −1,818 $84.58 $153,766 109,491 D
Open-market sales · 8,000 sh · avg $83.85 · $670,823

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-02-18 Exercise or conversion : show line 4 in the form 10b5-1 Stock Option (right to buy) −8,000 246,827 D
Loading xslF345X05/wk-form4_1740006233.xml…